Trial Profile
A prospective study investigating efficacy of intravitreal pegaptanib sodium in treatment-naive patients with neovascular age-related macular degeneration as maintenance therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 27 Feb 2016 New trial record